Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bazarbachi

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Virus Research|August 25, 2001
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectivesA Bazarbachi, O Hermine
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patientsA Bazarbachi, O Hermine
Pathologie-Biologie|June 30, 2012
[Chronic myeloid leukemia: "archetype" of the impact of targeted therapies]R Nasr, A Bazarbachi
Bulletin Du Cancer|January 1, 1995
[Role of retroviruses in human cancerogenesis]A Bazarbachi, M Canivet, J Periès
Leukemia|November 24, 2006
Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein TaxN Darwiche, G Abou-Lteif, A Bazarbachi
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Adult T cell leukaemia: a review of established and new treatmentsO Hermine, E Wattel, A Gessain, et al.
Tissue Antigens|June 16, 2006
Distribution of killer cell immunoglobulin-like receptors genotypes in the Lebanese populationR Mahfouz, R Rayes, Z Mahfoud, et al.
Bone Marrow Transplantation|September 13, 2016
Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?E H Phillips, A Hodson, O Hermine, et al.
Meta Gene|January 22, 2015
KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genesR Hoteit, A Bazarbachi, A Antar, et al.
Virologie (Montrouge, France)|April 4, 2023
[Interactions between Tax of HTLV1 and cellular factors]E Chiari, R Nasr, A Favre-Bonvin, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Virus Research|August 25, 2001
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectivesA Bazarbachi, O Hermine
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patientsA Bazarbachi, O Hermine
Pathologie-Biologie|June 30, 2012
[Chronic myeloid leukemia: "archetype" of the impact of targeted therapies]R Nasr, A Bazarbachi
Bulletin Du Cancer|January 1, 1995
[Role of retroviruses in human cancerogenesis]A Bazarbachi, M Canivet, J Periès
Leukemia|November 24, 2006
Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein TaxN Darwiche, G Abou-Lteif, A Bazarbachi
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Adult T cell leukaemia: a review of established and new treatmentsO Hermine, E Wattel, A Gessain, et al.
Tissue Antigens|June 16, 2006
Distribution of killer cell immunoglobulin-like receptors genotypes in the Lebanese populationR Mahfouz, R Rayes, Z Mahfoud, et al.
Bone Marrow Transplantation|September 13, 2016
Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?E H Phillips, A Hodson, O Hermine, et al.
Meta Gene|January 22, 2015
KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genesR Hoteit, A Bazarbachi, A Antar, et al.
Virologie (Montrouge, France)|April 4, 2023
[Interactions between Tax of HTLV1 and cellular factors]E Chiari, R Nasr, A Favre-Bonvin, et al.
Pageof 6